Voyageur Pharmaceuticals Ltd.
OTC: VYYRF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Brent Willis
- Employees
- 6
- Headquarters
- Calgary, Canada
- IPO year
- 2017
- Market cap
- $17.9M
- Website
- https://voyageurpharmaceuticals.ca
Loading VYYRF…
Loading profile data…Frequently asked questions about VYYRF
What does Voyageur Pharmaceuticals Ltd. (VYYRF) do?
Voyageur Pharmaceuticals Ltd. is dedicated to extracting active pharmaceutical ingredients (APIs) from various mineral resources. The firm's strategic objectives include manufacturing radiocontrast compounds derived from barium and iodine, in addition to developing pharmaceuticals that incorporate bromine. The company boasts complete ownership o...
Where does VYYRF trade?
Voyageur Pharmaceuticals Ltd. (VYYRF) trades on the Other OTC.
What sector is VYYRF in?
Voyageur Pharmaceuticals Ltd. (VYYRF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Voyageur Pharmaceuticals Ltd.?
Brent Willis is the chief executive officer of Voyageur Pharmaceuticals Ltd. (VYYRF).
Where is Voyageur Pharmaceuticals Ltd. headquartered?
Voyageur Pharmaceuticals Ltd. is headquartered in Canada.
Does VYYRF pay a dividend?
Voyageur Pharmaceuticals Ltd. (VYYRF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VYYRF go public?
Voyageur Pharmaceuticals Ltd. (VYYRF) completed its initial public offering in 2017.